Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement

被引：32
|
作者：
Marmont, A. M. [1 ]
Gualandi, F.
Piaggio, G.
Podesta, M.
van Lint, M. Teresa
Bacigalupo, A.
Nobili, F.
机构：
[1] Azienda Osped Univ San Martino, Div Hematol, Genoa, Italy
[2] Azienda Osped Univ San Martino, Stem Cell Transplantat Ctr, Genoa, Italy
[3] Azienda Osped Univ San Martino, Inst Clin Neurophysiol, Genoa, Italy
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷 / 11期
关键词：
D O I：
10.1038/sj.bmt.1705372
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1061 / 1063
页数：3
相关论文
共 50 条
  • [31] Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)
    Vindelov, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (02) : 73 - 82
  • [32] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [33] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    Bone Marrow Transplantation, 1997, 20 : 369 - 374
  • [34] Bone marrow transplantation (BMT) in patients with severe congenital neutropenia (SCN) refractory to G-CSF.
    Zeidler, C
    Levine, JE
    Bolyard, A
    Bonilla, MA
    Boxer, L
    Brown, S
    Dale, DC
    Cham, B
    Fier, C
    Freedman, M
    Kannourakis, G
    Kinsey, SE
    Mori, P
    Welte, K
    BLOOD, 1998, 92 (10) : 136A - 136A
  • [35] Bone marrow transplantation (BMT) and Chagas disease.
    Feldman, L
    Requejo, A
    Jaimovich, G
    Milovic, V
    Listello, V
    Rivas, MM
    Puente, D
    Altclas, J
    BLOOD, 2003, 102 (11) : 442B - 443B
  • [36] Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation
    Saad, Ali G.
    Alyea, Edwin P., III
    Wen, Patrick Y.
    DeGirolami, Umberto
    Kesari, Santosh
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : E147 - E149
  • [37] Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): Impact on CNS disease.
    Walters, MC
    Patience, M
    Leisenring, W
    Steen, RG
    Zamani, C
    Vichinsky, E
    Storb, R
    Sullivan, KM
    BLOOD, 2002, 100 (11) : 45A - 46A
  • [38] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) AS TREATMENT FOR EXTRAMEDULLARY RELAPSE AFTER ALLOGENEIC BMT
    MILPIED, N
    HAROUSSEAU, JL
    BOURHIS, JH
    GUIMBRETIERE, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 307 - 307
  • [39] Severe hemosiderosis post allogeneic bone marrow transplantation
    Mahendra, P
    Hood, IM
    Bass, G
    Patterson, P
    Marcus, RE
    HEMATOLOGICAL ONCOLOGY, 1996, 14 (01) : 33 - 35
  • [40] B-CELL LYMPHOPROLIFERATIVE DISEASE (BLPD) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    FILIPOVICH, AH
    SHAPIRO, RS
    MCCLAIN, K
    PATTON, DF
    BLAZAR, BR
    GREENBERG, J
    KERSEY, JH
    GAJLPECZALSKA, K
    FRIZZERA, G
    BURKE, B
    MCGLAVE, PB
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 592 - 592
12345